Gelteq (Nasdaq:GELS) - Stock Price, News & Analysis

GELS Stock Overview

Focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals. More details

GELS fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	1/6
Dividends	0/6

Risk Analysis

Has less than 1 year of cash runway

Earnings have declined by 33.4% per year over past 5 years

Shares are highly illiquid

Makes less than USD$1m in revenue (A$143K)

+ 1 more risk

Gelteq Limited Competitors

Cingulate

NasdaqCM:CING

US$14.0m

TherapeuticsMD

NasdaqGS:TXMD

US$16.1m

Bright Green

OTCPK:BGXX

US$16.3m

Cumberland Pharmaceuticals

NasdaqGS:CPIX

US$15.6m

Price History & Performance

Summary of all time highs, changes and price drops for Gelteq
Historical stock prices
Current Share Price	US$1.86
52 Week High	US$4.01
52 Week Low	US$1.42
Beta	0
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-36.73%

Recent updates

Shareholder Returns

	GELS	US Pharmaceuticals	US Market
7D	23.2%	4.2%	2.0%
1Y	n/a	13.7%	32.4%

Return vs Industry: Insufficient data to determine how GELS performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GELS performed against the US Market.

Price Volatility

Is GELS's price volatile compared to industry and market?
GELS volatility
GELS Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	9.7%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.9%
10% least volatile stocks in US Market	3.1%

Stable Share Price: GELS's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GELS's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2017	8	Nathan Givoni	www.gelteq.com

Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.

Gelteq Limited Fundamentals Summary

How do Gelteq's earnings and revenue compare to its market cap?
GELS fundamental statistics
Market cap	US$17.55m
Earnings (TTM)	-US$2.30m
Revenue (TTM)	US$93.13k

188.5x

P/S Ratio

-7.6x

P/E Ratio

Is GELS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GELS income statement (TTM)
Revenue	AU$143.31k
Cost of Revenue	AU$0
Gross Profit	AU$143.31k
Other Expenses	AU$3.69m
Earnings	-AU$3.55m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.38
Gross Margin	100.00%
Net Profit Margin	-2,474.44%
Debt/Equity Ratio	25.4%

How did GELS perform over the long term?

See historical performance and comparison

Gelteq NasdaqCM:GELS Stock Report